Literature DB >> 31779858

Prevalence of hypertension among Indian adults: Results from the great India blood pressure survey.

Sivasubramanian Ramakrishnan, Geevar Zachariah, Kartik Gupta, J Shivkumar Rao, P P Mohanan, K Venugopal, Santosh Sateesh, Rishi Sethi, Dharmendra Jain, Neil Bardolei, Kalaivani Mani, Tanya Singh Kakar, Bharathraj Kidambi, Sudha Bhushan, Sunil K Verma, Balram Bhargava, Ambuj Roy, Shyam S Kothari, Rajeev Gupta, Sandeep Bansal, Sanjay Sood, Ranjit K Nath, Sanjay Tyagi, Mohit D Gupta, M P Girish, I P S Kalra, G S Wander, Satish Gupta, Subroto Mandal, Nagendra Boopathy Senguttuvan, Geetha Subramanyam, Debabatra Roy, Sibananda Datta, Kajal Ganguly, S N Routray, S S Mishra, B P Singh, B B Bharti, Mrinal K Das, Soumitra Kumar, K C Goswami, V K Bahl, Sarat Chandra, Amal Banerjee, Santanu Guha, P K Deb, H K Chopra, Prakash Deedwania, Ashok Seth.   

Abstract

OBJECTIVE: Hypertension is the most important risk factor for cardiovascular morbidity and mortality. There is limited data on hypertension prevalence in India. This study was conducted to estimate the prevalence of hypertension among Indian adults.
METHODS: A national level survey was conducted with fixed one-day blood pressure measurement camps across 24 states and union territories of India. Hypertension was defined as systolic blood pressure (BP) ≥140 mmHg or a diastolic BP ≥90 mmHg or on treatment for hypertension. The prevalence was age- and gender-standardized according to the 2011 census population of India.
RESULTS: Blood pressure was recorded for 180,335 participants (33.2% women; mean age 40.6 ± 14.9 years). Among them, 8,898 (4.9%), 99,791 (55.3%), 35,694 (11.9%), 23,084 (12.8%), 9,989 (5.5%), and 2,878 (1.6%) participants were of the age group 18-19, 20-44, 45-54, 55-64, 65-74, and ≥ 75 years, respectively. Overall prevalence of hypertension was 30.7% (95% confidence interval [CI]: 30.5, 30.9) and the prevalence among women was 23.7% (95% CI: 23.3, 24). Prevalence adjusted for 2011 census population and the WHO reference population was 29.7% and 32.8%, respectively.
CONCLUSION: There is a high prevalence of hypertension, with almost one in every three Indian adult affected.
Copyright © 2019 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hypertension; India; Prevalence

Mesh:

Year:  2019        PMID: 31779858      PMCID: PMC6890959          DOI: 10.1016/j.ihj.2019.09.012

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


Introduction

Cardiovascular diseases remain the top cause of global mortality, with an estimated 17.9 million attributed deaths in 2016 (31% of global deaths). Hypertension is consistently related to the development of ischemic heart disease, heart failure, stroke, and chronic kidney disease; an estimated 57% and 24% of stroke and coronary artery disease-related deaths, respectively are due to hypertension.2, 3, 4, 5 According to the global burden of diseases estimate 2015, it is the most important cause of mortality as well as the loss of disability-adjusted life years. Since the early 1950s, there have been many studies in India reporting the prevalence of hypertension across various geographic, occupational, and linguistic groups.7, 8, 9, 10, 11, 12, 13 Analysis of worldwide data for estimation of the global prevalence of hypertension in 2005 highlighted the lack of a national study investigating the prevalence in India. There is also heterogeneity among the present studies in the method of measuring blood pressure (BP) (mercury and aneroid or electronic machines), the definition of hypertension, and enrollment of participants. This survey was conducted to estimate the prevalence of hypertension among Indian adults.

Materials and methods

Study setting

The study was conducted as a part of Cardiac Prevent 2015—under the aegis of the Cardiological Society of India. On 21 September 2015, from 9am to 5pm, we measured the BP of consecutive adult participants (age ≥18 years) attending the BP camp across 24 states and union territories of India. All participants gave informed written consent.

Hypertension definition

Hypertension was defined according to the Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7).

Blood pressure measurement and data collection

BP was measured using automated oscillometric machines. Before measuring BP, the participant should not have taken tea or coffee in the last 10 min and should have been seated for at least 5 min. Individuals with BP reading ≥140/90 mmHg had their BP remeasured after 3 min; the average of the two BP measurements was recorded. The average BP was rounded off to the nearest whole number. We recorded a self-reported history of hypertension, diabetes, and use of antihypertensive medications. A printed report of BP measurement was provided to the patient. Individual site coordinators were responsible for data collection which was fed real-time into an online portal designed by the Cardiological Society of India. An independent auditor (not involved in data collection) reviewed and verified the number of participants from each site.

Statistical analysis

Total prevalence was age- and gender-standardized according to 2011 census population of India. Distribution of BP across the four classifications (normal, prehypertension, Stage I hypertension and Stage 2 hypertension) was calculated across six mutually exclusive age groups (18–19, 20–44, 45–54, 55–64, 65–74, and ≥ 75 years). Hypertension prevalence was also calculated according to the World Health Organization (WHO) world standard population for the year 2000–2025; as recommended by the World Hypertension League., All analyses were performed using STATA V15.0 (College Station, TX, USA) statistical software.

Results

Across 24 states and union territories of India a total of 180,335 participants [120,425 (66.8%) men and 59,910 (33.2%) women] with mean age 40.6 ± 14.9 years were surveyed. 8,898 (4.9%), 99,791 (55.3%), 35,694 (11.9%), 23,084 (12.8%), 9,989 (5.5%), and 2,878 (1.6%) subjects belonged to age group 18–19, 20–44, 45–54, 55–64, 65–74, and ≥ 75 years respectively. Prevalence of self-reported hypertension and diabetes was 15.9% and 10.1%, respectively. Overall prevalence of hypertension was 30.7% (95% confidence interval [CI]: 29.7, 32.8). Prevalence increased with age; with more men having hypertension in each age group, except in those with age ≥65 years, where almost equal percentage of men and women had hypertension (Table 1 and Fig. 1). Prevalence adjusted for 2011 census population of India was 29.7%; prevalence adjusted for the WHO reference population was 32.8%.
Table 1

Prevalence of hypertension.

Age (years)Men (n = 120,425)Women (n = 59,910)Total (n = 180,335)
18–19 (n = 8,898)16.1 (15.1, 17.0)6.2 (5.4, 7.0)12.2 (11.5, 12.9)
20–44 (n = 99,791)26.7 (26.4, 27.1)14 (13.6, 14.4)22.4 (22.2, 22.7)
45–54 (n = 35,694)42.4 (41.8, 43)34.6 (33.7, 35.4)39.8 (39.4, 40.3)
55–64 (n = 23,084)49.0 (48.2, 49.9)45.4 (44.2, 46.5)47.9 (47.2, 48.5)
65–74 (n = 9,989)51.5 (50.3, 52.7)51.4 (49.6, 53.3)51.5 (50.5, 52.4)
≥75 (n = 2,878)52.2 (50.1, 54.4)51.3 (47.8, 54.8)52.0 (50.2, 53.8)
Total (n = 180,335)34.2 (33.9, 34.5)23.7 (23.3, 24.0)30.7 (30.5, 30.9)

Data as percentage (95% confidence interval).

Fig. 1

Prevalence of hypertension, according to age group and gender.

Prevalence of hypertension. Data as percentage (95% confidence interval). Prevalence of hypertension, according to age group and gender. Both systolic BP (SBP) and diastolic BP (DBP) were higher among men than women across all age groups (Fig. 1). Mean SBP and DBP according to age group is given in Table 2. Mean SBP and DBP increased with increasing age in both genders till age 65 years after which it reached a plateau (Fig. 2A and B).
Table 2

Mean systolic and diastolic blood pressure.

MenWomenTotal
Age (years)41.1 ± 15 (29–52)39.7 ± 14.7 (27–50)40.6 ± 14.9 (28–51)
Mean SBP (mmHg)
 18–19121.4 ± 15 (110–130)111.4 ± 12.4 (102–120)117.5 ± 14.9 (110–127)
 20–44124.1 ± 15.1 (114–130)115.6 ± 15.0 (108–122)121.2 ± 15.6 (110–130)
 45–54130.2 ± 18.2 (120–140)126.7 ± 18.0 (113–140)129.0 ± 18.2 (119–140)
 55–64134.1 ± 19.5 (120–144)132.4 ± 19.3 (120–140)133.6 ± 19.5 (120–143)
 65–74136.5 ± 20.4 (120–150)136.0 ± 21.2 (120–149.5)136.4 ± 20.7 (120–150)
 ≥75137.2 ± 21.4 (120–150)136.0 ± 22.7 (120–148)136.8 ± 21.8 (120–150)
 Total127.5 ± 17.5 (117–138)120.8 ± 18.2 (110–130)125.3 ± 18.0 (110–135)
Mean DBP (mmHg)
 18–1974.8 ± 11 (69–80)71.9 ± 9.6 (66–80)73.7 ± 10.6 (68–80)
 20–4479.6 ± 10.9 (70–86)75.1 ± 10.4 (70–80)78.1 ± 10.9 (70–84)
 45–5483.2 ± 11.7 (77–90)80.3 ± 10.9 (70–90)82.2 ± 11.5 (75–90)
 55–6482.9 ± 11.6 (76–90)81.1 ± 11.0 (73–90)82.4 ± 11.4 (76–90)
 65–7481.8 ± 11.9 (74–90)80.8 ± 11.9 (70–90)81.5 ± 11.9 (72–90)
 ≥7580.1 ± 12.4 (70–90)80.6 ± 12.9 (70–90)80.2 ± 12.5 (70–90)
 Total80.6 ± 11.4 (72–90)77.0 ± 11.0 (70–81)79.5 ± 11.4 (70–87)

Data as mean ± standard deviation (25th to 75th percentile).

SBP: systolic blood pressure; DBP: diastolic blood pressure.

Fig. 2

A. Mean systolic blood pressure (SBP) across age groups. B. Mean diastolic blood pressure (DBP) across age groups.

Mean systolic and diastolic blood pressure. Data as mean ± standard deviation (25th to 75th percentile). SBP: systolic blood pressure; DBP: diastolic blood pressure. A. Mean systolic blood pressure (SBP) across age groups. B. Mean diastolic blood pressure (DBP) across age groups. Among those not on any antihypertensive medication, only 28.6% of participants were found to have normal BP. Most participants were in the prehypertension stage (Table 3). 42.9% in the age group of 18–19 years had prehypertension.
Table 3

Characteristics of Indian adults by blood pressure categories.

SBP/DBP categories among those not taking Anti-HTN medications
Taking Anti-HTN Medication (n = 23,213)
Normal BP<120/<80 mmHgPrehypertension120-139/80–89 mmHgStage 1 HTN140-159/90–99 mmHgStage 2 HTN ≥160/≥100 mmHg
Age (years)
 18–193,983 (45.0)3,797 (42.9)998 (11.3)73 (0.8)47 (0.2)
 20–4431,018 (32.6)44,222 (46.5)18,290 (19.2)1,674 (1.8)4,587 (19.8)
 45–546,021 (20.8)12,625 (43.7)8,744 (30.2)1,526 (5.3)6,778 (29.2)
 55–642,689 (16.7)6,566 (40.7)5,461 (33.8)1,411 (8.8)6,957 (30.0)
 65–74951 (15.2)2,454 (39.3)2,094 (33.6)740 (11.9)3,750 (16.2)
 ≥75307 (17.2)677 (44.8)584 (23.0)216 (3.6)3,750 (4.7)
Men23,690 (22.6)49,291 (47.0)27,644 (26.3)4,358 (4.2)15,442 (66.5)
Women21,280 (40.8)21,050 (40.4)8,527 (16.4)1,282 (2.5)7,771 (33.5)
Total44,970 (28.6)70,341 (44.8)55,850 (23.0)5,640 (3.6)23,213 (12.9)

Data as n (percentage). SBP: systolic blood pressure; DBP: diastolic blood pressure; HTN: hypertension.

Characteristics of Indian adults by blood pressure categories. Data as n (percentage). SBP: systolic blood pressure; DBP: diastolic blood pressure; HTN: hypertension. There were 12.9% (95% CI, 12.7–13.0) subjects on antihypertensive medications. Of total 55,370 participants with hypertension, 28,614 (51.4%) were aware of their disease status. Of those who were aware, 23,213 (81.1%) were on any antihypertensive medication. Of those on medication, only 13,545 (41.6%) had BP within the target (SBP<140 mmHg and DBP<90 mmHg).

Discussion

We report a high prevalence of hypertension among Indian adults, with almost one in three participants having hypertension. There are around 762 million Indians ≥18 years of age in India, which means there are currently 234 million adults with hypertension. A similar prevalence of 26.5% was reported by a study using health survey–based nationwide blood pressure data (n = 1,320,555). Data from the National Family Health Survey-4 (NFHS-4) (n = 802,927) suggest a much lower prevalence of 11.3%. This could be due to the overrepresentation of women (87.2% in NFHS-4 vs. 34.3% in our study) and a younger study population (15–49 years) in NFHS-4. Anchala et al reported a similar prevalence of 29.8% in their meta-analysis where they pooled results from 142 hypertension prevalence studies from 1950 to 2013, representing around 0.3 million subjects. Trends from the noncommunicable disease (NCD) Risk factor Collaboration (NCD-RisC) suggest that from 1975 to 2015, the mean systolic and diastolic blood pressure, as well as the prevalence of hypertension in the Indian population, has remained stable. Studies included in this analysis varied in their methodology and population selection. This is the first time that the NFHS has collected data on noncommunicable diseases such as obesity and hypertension. In subsequent years, this data will help better understand the epidemiological trends. We found a high prevalence of hypertension among young adults (20–44 years). The prevalence in this age group is more than twice the prevalence in a similar population in the United States (22.4% vs. 10.5%, respectively). This increased prevalence of hypertension and prehypertension among young Indians is being increasingly reported.24, 25, 26 This is a disturbing trend because it puts an increasing number of young Indians at an increased risk of premature mortality due to cardiovascular causes. Currently, Indians experience cardiovascular event–related deaths almost a decade earlier than developed countries, with cardiovascular events responsible for 52% of all deaths in those aged <70 years in India, as compared with 23% in these countries. The increasing trend in both systolic and diastolic BP till the fifth and the sixth decade followed by a decline in the diastolic BP observed in our study suggests that isolated systolic hypertension is the predominant form of hypertension in the elderly., We observed a higher proportion of participants who were aware, on treatment, and had controlled BP than was reported by Roy et al (51.0% vs. 38.7%, 88.0% vs. 32.3%, and 41.0% vs. 12.8% respectively). A probable reason could be that the population we surveyed was mostly working class and there could be a behavioral bias among those getting their BP measured, with those more educated, aware, and concerned about their health status attending the camp. The awareness of high blood pressure was, however, much lower than that reported in similar studies from Canada (83%), the USA (81%), or England (65%). It is estimated that around 17.6% of patients with hypertension globally live in India, which suggests an expected large increase in cardiovascular diseases burden in the near future.,, This mandates early detection and treatment, as adequate BP control can avert almost a third of all cardiovascular-related mortality. Homogenous data collection, real-time feeding of data in the online system, and independent review of all readings are the strengths of this study. For the first time, we report the genderwise prevalence of hypertension across age groups. There are, however, some limitations. The study may have a selection bias as the healthy volunteers usually turn up for checkups. However, the effect of this bias is likely to be small given the large sample size.

Conclusion

There is a very high prevalence of hypertension among Indian adults, across all age groups. In addition, there is poor awareness, treatment, and control among those with hypertension. Regional prevalence of hypertension in specific geographical locations. Age group and gender wise prevalence of hypertension through nationally representative data. Prevalence standardized to the census population and WHO standard population.

Conflicts of interest

All authors have none to declare.
What is already known?

Regional prevalence of hypertension in specific geographical locations.

What does this study add?

Age group and gender wise prevalence of hypertension through nationally representative data.

Prevalence standardized to the census population and WHO standard population.

  29 in total

1.  The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke: A Modeling Study From the American Heart Association and World Heart Federation.

Authors:  Ralph L Sacco; Gregory A Roth; K Srinath Reddy; Donna K Arnett; Ruth Bonita; Thomas A Gaziano; Paul A Heidenreich; Mark D Huffman; Bongani M Mayosi; Shanthi Mendis; Christopher J L Murray; Pablo Perel; Daniel J Piñeiro; Sidney C Smith; Kathryn A Taubert; David A Wood; Dong Zhao; William A Zoghbi
Journal:  Circulation       Date:  2016-05-09       Impact factor: 29.690

2.  Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.

Authors:  Paul Muntner; Robert M Carey; Samuel Gidding; Daniel W Jones; Sandra J Taler; Jackson T Wright; Paul K Whelton
Journal:  Circulation       Date:  2017-11-13       Impact factor: 29.690

3.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

4.  Blood pressure as a risk factor for cardiovascular disease. The Framingham Study--30 years of follow-up.

Authors:  J Stokes; W B Kannel; P A Wolf; R B D'Agostino; L A Cupples
Journal:  Hypertension       Date:  1989-05       Impact factor: 10.190

5.  Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study.

Authors:  Michel Joffres; Emanuela Falaschetti; Cathleen Gillespie; Cynthia Robitaille; Fleetwood Loustalot; Neil Poulter; Finlay A McAlister; Helen Johansen; Oliver Baclic; Norm Campbell
Journal:  BMJ Open       Date:  2013-08-30       Impact factor: 2.692

6.  Changes in hypertension prevalence, awareness, treatment and control rates over 20 years in National Capital Region of India: results from a repeat cross-sectional study.

Authors:  Ambuj Roy; Pradeep A Praveen; Ritvik Amarchand; Lakshmy Ramakrishnan; Ruby Gupta; Dimple Kondal; Kalpana Singh; Meenakshi Sharma; Deepak Kumar Shukla; Nikhil Tandon; Kolli Srinath Reddy; Anand Krishnan; Dorairaj Prabhakaran
Journal:  BMJ Open       Date:  2017-07-12       Impact factor: 2.692

7.  Alarmingly high prevalence of hypertension and pre-hypertension in North India-results from a large cross-sectional STEPS survey.

Authors:  Jaya Prasad Tripathy; Jarnail Singh Thakur; Gursimer Jeet; Sohan Chawla; Sanjay Jain
Journal:  PLoS One       Date:  2017-12-21       Impact factor: 3.240

8.  Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet       Date:  2017-09-16       Impact factor: 79.321

9.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Rafael Lozano; Mohsen Naghavi; Kyle Foreman; Stephen Lim; Kenji Shibuya; Victor Aboyans; Jerry Abraham; Timothy Adair; Rakesh Aggarwal; Stephanie Y Ahn; Miriam Alvarado; H Ross Anderson; Laurie M Anderson; Kathryn G Andrews; Charles Atkinson; Larry M Baddour; Suzanne Barker-Collo; David H Bartels; Michelle L Bell; Emelia J Benjamin; Derrick Bennett; Kavi Bhalla; Boris Bikbov; Aref Bin Abdulhak; Gretchen Birbeck; Fiona Blyth; Ian Bolliger; Soufiane Boufous; Chiara Bucello; Michael Burch; Peter Burney; Jonathan Carapetis; Honglei Chen; David Chou; Sumeet S Chugh; Luc E Coffeng; Steven D Colan; Samantha Colquhoun; K Ellicott Colson; John Condon; Myles D Connor; Leslie T Cooper; Matthew Corriere; Monica Cortinovis; Karen Courville de Vaccaro; William Couser; Benjamin C Cowie; Michael H Criqui; Marita Cross; Kaustubh C Dabhadkar; Nabila Dahodwala; Diego De Leo; Louisa Degenhardt; Allyne Delossantos; Julie Denenberg; Don C Des Jarlais; Samath D Dharmaratne; E Ray Dorsey; Tim Driscoll; Herbert Duber; Beth Ebel; Patricia J Erwin; Patricia Espindola; Majid Ezzati; Valery Feigin; Abraham D Flaxman; Mohammad H Forouzanfar; Francis Gerry R Fowkes; Richard Franklin; Marlene Fransen; Michael K Freeman; Sherine E Gabriel; Emmanuela Gakidou; Flavio Gaspari; Richard F Gillum; Diego Gonzalez-Medina; Yara A Halasa; Diana Haring; James E Harrison; Rasmus Havmoeller; Roderick J Hay; Bruno Hoen; Peter J Hotez; Damian Hoy; Kathryn H Jacobsen; Spencer L James; Rashmi Jasrasaria; Sudha Jayaraman; Nicole Johns; Ganesan Karthikeyan; Nicholas Kassebaum; Andre Keren; Jon-Paul Khoo; Lisa Marie Knowlton; Olive Kobusingye; Adofo Koranteng; Rita Krishnamurthi; Michael Lipnick; Steven E Lipshultz; Summer Lockett Ohno; Jacqueline Mabweijano; Michael F MacIntyre; Leslie Mallinger; Lyn March; Guy B Marks; Robin Marks; Akira Matsumori; Richard Matzopoulos; Bongani M Mayosi; John H McAnulty; Mary M McDermott; John McGrath; George A Mensah; Tony R Merriman; Catherine Michaud; Matthew Miller; Ted R Miller; Charles Mock; Ana Olga Mocumbi; Ali A Mokdad; Andrew Moran; Kim Mulholland; M Nathan Nair; Luigi Naldi; K M Venkat Narayan; Kiumarss Nasseri; Paul Norman; Martin O'Donnell; Saad B Omer; Katrina Ortblad; Richard Osborne; Doruk Ozgediz; Bishnu Pahari; Jeyaraj Durai Pandian; Andrea Panozo Rivero; Rogelio Perez Padilla; Fernando Perez-Ruiz; Norberto Perico; David Phillips; Kelsey Pierce; C Arden Pope; Esteban Porrini; Farshad Pourmalek; Murugesan Raju; Dharani Ranganathan; Jürgen T Rehm; David B Rein; Guiseppe Remuzzi; Frederick P Rivara; Thomas Roberts; Felipe Rodriguez De León; Lisa C Rosenfeld; Lesley Rushton; Ralph L Sacco; Joshua A Salomon; Uchechukwu Sampson; Ella Sanman; David C Schwebel; Maria Segui-Gomez; Donald S Shepard; David Singh; Jessica Singleton; Karen Sliwa; Emma Smith; Andrew Steer; Jennifer A Taylor; Bernadette Thomas; Imad M Tleyjeh; Jeffrey A Towbin; Thomas Truelsen; Eduardo A Undurraga; N Venketasubramanian; Lakshmi Vijayakumar; Theo Vos; Gregory R Wagner; Mengru Wang; Wenzhi Wang; Kerrianne Watt; Martin A Weinstock; Robert Weintraub; James D Wilkinson; Anthony D Woolf; Sarah Wulf; Pon-Hsiu Yeh; Paul Yip; Azadeh Zabetian; Zhi-Jie Zheng; Alan D Lopez; Christopher J L Murray; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

10.  Hypertension in the elderly: prevalence and health seeking behavior.

Authors:  Palanivel Chinnakali; Bharathy Mohan; Ravi Prakash Upadhyay; Arvind Kumar Singh; Rahul Srivastava; Kapil Yadav
Journal:  N Am J Med Sci       Date:  2012-11
View more
  31 in total

Review 1.  Therapeutic Usefulness of a Novel Calcium Channel Blocker Azelnidipine in the Treatment of Hypertension: A Narrative Review.

Authors:  C Venkata S Ram
Journal:  Cardiol Ther       Date:  2022-08-13

2.  Prevalence and Predictors of Nonalcoholic Fatty Liver Disease in Family Members of Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Abhinav Anand; Amit A Singh; Anshuman Elhence; Manas Vaishnav; Sagnik Biswas; Deepak Gunjan; Shivanand R Gamanagatti; Baibaswata Nayak; Ramesh Kumar
Journal:  J Clin Exp Hepatol       Date:  2021-07-31

3.  Stroke Awareness among Hypertensive Patients: Institutional Based Survey in Western Rajasthan, India.

Authors:  Sunita K Chaudhary; Ashok Kumar; Nimarta Rana; Samhita Panda; Naresh K Midha
Journal:  Ann Indian Acad Neurol       Date:  2022-04-25       Impact factor: 1.714

4.  Descriptive profile of risk factors for cardiovascular diseases using WHO STEP wise approach in Madhya Pradesh.

Authors:  Arun M Kokane; Rajnish Joshi; Ashwin Kotnis; Anirban Chatterjee; Kriti Yadav; G Revadi; Ankur Joshi; Abhijit P Pakhare
Journal:  PeerJ       Date:  2020-08-06       Impact factor: 2.984

5.  Effectiveness of Telmisartan on Blood Pressure Control in Hypertensive Patients in India: A Real-World Retrospective Study from Electronic Medical Records.

Authors:  Mohammed Yunus Khan; Sucheta Pandit; Jabir Abdulkutty; Girish Navasundi; Prakash Kumar Hazra; Uday Phadke; Amey Mane; Suyog Mehta; Snehal Shah
Journal:  Cardiol Ther       Date:  2021-04-08

6.  Social and behavioural risk factors in the prevention and management of cardiovascular disease in Kerala, India: a catchment area population survey.

Authors:  Saju Madavanakadu Devassy; Martin Webber; Lorane Scaria; Jotheeswaran Amuthavalli Thiyagarajan; Meredith Fendt-Newlin; Jacques Joubert; Anuja Maria Benny; Anjana Nannatt; Lynette Joubert
Journal:  BMC Cardiovasc Disord       Date:  2020-07-08       Impact factor: 2.298

7.  Burden of hypertension in India.

Authors:  Manas Pratim Roy
Journal:  Indian Heart J       Date:  2020-05-11

8.  Rationale, design, and baseline characteristics of the Salt Substitute in India Study (SSiIS): The protocol for a double-blinded, randomized-controlled trial.

Authors:  Sudhir Raj Thout; Jie Yu; Maoyi Tian; Mark D Huffman; Clare Arnott; Qiang Li; Praveen Devarsetty; Claire Johnson; Simone Pettigrew; Bruce Neal; Jason H Y Wu
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-07-25       Impact factor: 3.738

9.  Expanding statin use for prevention of ASCVD in Indians: Reasoned and simplified proposals.

Authors:  Enas A Enas; Basil Varkey; Rajeev Gupta
Journal:  Indian Heart J       Date:  2020-04-08

10.  COVID-19 Risk Assessment Tool: Dual application of risk communication and risk governance.

Authors:  Ranit Chatterjee; Sukhreet Bajwa; Disha Dwivedi; Repaul Kanji; Moniruddin Ahammed; Rajib Shaw
Journal:  Prog Disaster Sci       Date:  2020-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.